IRIS
GIANNONI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.777
EU - Europa 4.020
AS - Asia 728
Continente sconosciuto - Info sul continente non disponibili 28
AF - Africa 9
OC - Oceania 8
SA - Sud America 8
Totale 11.578
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.449
GB - Regno Unito 1.347
IT - Italia 797
UA - Ucraina 556
DE - Germania 424
CA - Canada 326
DK - Danimarca 268
VN - Vietnam 264
CN - Cina 253
SE - Svezia 224
IE - Irlanda 171
HK - Hong Kong 124
FI - Finlandia 78
FR - Francia 63
PL - Polonia 38
EU - Europa 27
SG - Singapore 26
PK - Pakistan 20
NL - Olanda 10
RU - Federazione Russa 10
RO - Romania 9
BD - Bangladesh 7
IN - India 7
CH - Svizzera 6
AU - Australia 5
MG - Madagascar 5
MT - Malta 5
ES - Italia 4
IR - Iran 4
JP - Giappone 4
PH - Filippine 4
TH - Thailandia 4
NZ - Nuova Zelanda 3
AM - Armenia 2
BR - Brasile 2
CL - Cile 2
CO - Colombia 2
GH - Ghana 2
HR - Croazia 2
ID - Indonesia 2
IL - Israele 2
MX - Messico 2
NP - Nepal 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TR - Turchia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
CZ - Repubblica Ceca 1
NO - Norvegia 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
ZA - Sudafrica 1
Totale 11.578
Salva come PNG Salva come JPEG
Città #
Southend 907
Chandler 733
Fairfield 584
Houston 490
Woodbridge 468
San Mateo 436
Ann Arbor 422
Falls Church 406
Cambridge 331
Jacksonville 320
Seattle 318
Wilmington 285
Ashburn 239
Ottawa 239
Dearborn 214
Dublin 169
Stevenage 164
Portsmouth 163
Beijing 151
Dong Ket 147
Lawrence 132
Pisa 110
Boardman 90
Montréal 72
San Diego 61
Rome 60
Fremont 53
Milan 41
Redwood City 39
London 38
Brooklyn 37
Warsaw 36
Helsinki 33
Old Bridge 27
Central District 26
Norwalk 23
Florence 18
Hong Kong 18
Washington 18
Livorno 16
Genoa 13
Los Angeles 13
Serra 13
Dallas 12
Shenzhen 11
Guangzhou 10
Kilburn 9
Nanjing 9
Redmond 9
Hanover 8
Islamabad 8
Lucca 8
Mykolayiv 8
Amsterdam 7
Buti 7
Chengdu 7
Dongguan 7
Frankfurt am Main 7
Laurel 7
Wandsworth 7
Bucharest 6
Cascina 6
Foggia 6
Pescia 6
Toronto 6
Venice 6
Viareggio 6
Augusta 5
Bari 5
Casalecchio di Reno 5
Iowa City 5
Islington 5
Lyngby 5
Mariano Comense 5
Medolago 5
Melita 5
Paris 5
Perugia 5
Sciacca 5
Turin 5
Wuhan 5
Bologna 4
Lahore 4
Naples 4
Palermo 4
San Antonio 4
Simi Valley 4
West Jordan 4
Agordo 3
Albavilla 3
Anzio 3
Auckland 3
Berlin 3
Capriate San Gervasio 3
Catania 3
Chicago 3
Chiswick 3
Glostrup 3
Hefei 3
Hyderabad 3
Totale 8.490
Salva come PNG Salva come JPEG
Nome #
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 225
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 171
Treating chemoreflex in heart failure: modulation or demolition? 163
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 159
B-type natriuretic peptide secretion following scuba diving 155
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 152
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 146
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 146
Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea 143
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 143
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 142
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 142
Changes in chemoreflex characteristics following acetazolamide administration in patients with chronic heart failure and Cheyne Stokes respiration 139
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 136
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 132
Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients. 128
Prognostic value of plasma Renin activity in heart failure. 128
Diagnosis of preclinical /mild heart failure with B-type natriuretic peptides: compariosn betwwen BNP and NT-proBNP immunoassay methods 128
Cheyne-Stokes respiration is associated with neurohormonal activation in patients with heart failure 127
Automatic analysis of EEG pattern during sleep in Cheyne-Stokesrespiration in heart failure. 127
Breathless heart: only when the neck is deep in water? 126
Risk factors and prognostic value of daytime Cheyne-Stokes respiration in chronic heart failure patients 125
Clinical significance of chemosensitivity in chronic heart failure: influence on neurohormonal derangement, Cheyne-Stokes respiration and arrhythmias. 122
Prediction of the chemoreflex gain by common clinical variables in heart failure 122
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 122
Effect of acetazolamide on chemosensitivity, Cheyne-Stokes respiration, and response to effort in patients with heart failure. 121
Modern diagnostic and therapeutical approach to cardiac AL amyloidosis and neuroendocrine model of heart failure: lessons from a clinical case. 121
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 120
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 120
Baroreflex sensitivity, assessed by a novel noninvasive method, holds prognostic value in systolic heart failure 119
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 119
When the heart is burning: Amino-terminal pro-brain natriuretic peptide as an early marker of cardiac involvement in active autoimmune rheumatic disease 118
Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones 116
Combined increased chemosensitivity to hypoxia and hypercapnia as a prognosticator in heart failure. 114
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 114
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 111
Plasma renin activity is an independent prognosticator in heart failure patients with kidney disease 109
COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead 105
The paradox of low BNP levels in obesity 100
Diabetes is a predictor of effort tolerance and ventilatory efficiency in patients with moderate systolic dysfunction on beta-blocker therapy 99
High-sensitivity troponin: a new tool for pathophysiological investigation and clinical practice 99
Adrenergic activation in heart failure: blockade or rebalance? 98
Funzione endocrina cardiaca nello scompenso determinanti clinici, neuroormonali ed emodinamici 98
How to take arms against central apneas in heart failure 96
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 94
Models of BOLD Signal Change in Breath Hold Studies and CO2 Challenges: Methodological Issues and Interpretation 93
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 92
Heart Failure Results in Inspiratory Muscle Dysfunction Irrespective of Left Ventricular Ejection Fraction 92
Noncardiovascular death after acute heart failure. Do not lose the war while fighting for the failing heart 89
Recent knowledges on chemosensitivity to hypoxia and hypercapnia in cardiovascular disease. 87
An atypical case of cardiac amyloidosis. 86
Cheyne-Stokes respiration and heart failure: pathophysiologicaland clinical implications 85
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 85
OVEREXPRESSION OF ANG-(1-7) IMPROVES CARDIAC FUNCTION AND ATTENUATES LEFT VENTRICULAR REMODELING 83
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 83
Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction 83
A simple echocardiographic score to rule out cardiac amyloidosis 83
Natruiretic peptides in heart failure. 82
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 82
The Importance of Visceral Feedbacks: Focus on Chemoreceptors 82
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 82
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 81
Upright Cheyne-Stokes Respiration in Patients With Heart Failure 79
Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure 78
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 78
Analysis of generic coupling between EEG activity and PETCO2 in free breathing and breath-hold tasks using Maximal Information Coefficient (MIC) 76
Unveiling a sudden unexplained death case by whole exome sequencing and bioinformatic analysis 75
Management of complications of cardiac amyloidosis: 10 questions and answers 72
Benefit of buspirone on chemoreflex and central apnoeas in heart failure: a randomized controlled crossover trial 71
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis 71
Exploratory analysis of nonlinear coupling between EEG global field power and end-tidal carbon dioxide in free breathing and breath-hold tasks 71
Validity of transit time–based blood pressure measurements in patients with and without heart failure or pulmonary arterial hypertension across different breathing maneuvers 69
Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction 69
Correlational analysis of electroencephalographic and end-tidal carbon dioxide signals during breath-hold exercise 69
Use of hypocapnia for improved risk stratification in pulmonary arterial hypertension: should we return to respiratory pathophysiology? 69
Ld-EEG Effective Brain Connectivity in Patients With Cheyne-Stokes Respiration 68
Improved survival in limited scleroderma-related pulmonary artery hypertension 67
Healthy hearts at hectic pace: From daily life stress to abnormal cardiomyocyte function and arrhythmias 66
Diaphragm function does not independently predict exercise intolerance in patients with precapillary pulmonary hypertension after adjustment for right ventricular function 66
Troponin in non-ischaemic dilated cardiomyopathy 65
Reply 65
Central And Obstructive Apneas in Heart Failure With Reduced, Mid-Range And Preserved Ejection Fraction. 64
The Breathless Heart - Apneas in Heart Failure 64
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 63
Effects of central apneas on sympathovagal balance and hemodynamics at night: impact of underlying systolic heart failure 63
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction 63
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 62
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 62
Contribution of the lung to the genesis of cheyne-stokes respiration in heart failure: Plant gain beyond chemoreflex gain and circulation time 62
Effects of nasal high flow on sympathovagal balance, sleep, and sleep-related breathing in patients with precapillary pulmonary hypertension 62
Arterial hypertension and the turbulent ageing of the aortic valve 61
APAP therapy does not improve impaired sleep quality and sympatho-vagal balance: a randomized trial in patients with obstructive sleep apnea and systolic heart failure 60
The analysis of left atrial function predicts the severity of functional impairment in chronic heart failure: The FLASH multicenter study 60
Reversal of ticagrelor-induced arrhythmias and cheyne-stokes respiration with aminophylline infusion 60
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 60
Energy metabolism in the normal and in the diabetic heart 59
Wet is bad: Residual congestion predicts worse prognosis in acute heart failure 58
Treatment of cardiac transthyretin amyloidosis: an update 57
Renin profiling predicts neurohormonal response to sacubitril/valsartan 56
Inspiratory muscle dysfunction and restrictive lung function impairment in congenital heart disease: Association with immune inflammatory response and exercise intolerance 55
Totale 9.685
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.780
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.780
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201930 0 0 0 0 0 0 0 0 0 0 13 17
2019/20201.271 37 34 58 82 173 171 197 69 165 45 50 190
2020/20213.396 277 365 154 306 167 542 330 217 177 207 198 456
2021/20222.330 146 385 113 278 71 43 239 431 151 247 55 171
2022/20231.643 133 154 83 209 220 243 17 143 253 32 81 75
2023/2024856 107 34 280 90 37 88 80 49 30 39 22 0
Totale 11.776